125 related articles for article (PubMed ID: 1626323)
1. Sensitivity in culture of epithelial cells from rhesus monkey kidney and human colon carcinoma to toxins A and B from Clostridium difficile.
Torres J; Camorlinga-Ponce M; Muñoz O
Toxicon; 1992 Apr; 30(4):419-26. PubMed ID: 1626323
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile toxins A and B can alter epithelial permeability and promote bacterial paracellular migration through HT-29 enterocytes.
Feltis BA; Wiesner SM; Kim AS; Erlandsen SL; Lyerly DL; Wilkins TD; Wells CL
Shock; 2000 Dec; 14(6):629-34. PubMed ID: 11131913
[TBL] [Abstract][Full Text] [Related]
3. Production of cytotoxins and enterotoxins by strains of Shigella and Salmonella isolated from children with bloody diarrhea.
Morales Espinosa RM; González-Valencia G; Muñoz O; Torres J
Arch Med Res; 1993; 24(1):13-21. PubMed ID: 8292872
[TBL] [Abstract][Full Text] [Related]
4. Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro.
Lima AA; Lyerly DM; Wilkins TD; Innes DJ; Guerrant RL
Infect Immun; 1988 Mar; 56(3):582-8. PubMed ID: 3343050
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of Clostridium difficile toxin A for human colonic and pancreatic carcinoma cell lines.
Kushnaryov VM; Redlich PN; Sedmak JJ; Lyerly DM; Wilkins TD; Grossberg SE
Cancer Res; 1992 Sep; 52(18):5096-9. PubMed ID: 1516066
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.
Riegler M; Sedivy R; Pothoulakis C; Hamilton G; Zacherl J; Bischof G; Cosentini E; Feil W; Schiessel R; LaMont JT
J Clin Invest; 1995 May; 95(5):2004-11. PubMed ID: 7738167
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile toxin A and toxin B inhibit YAP in the colonic epithelial cells.
Song J; Shen X; Huang Z; Liu Y; Cui L; Cui X; Liu CY
J Biochem Mol Toxicol; 2021 Feb; 35(2):e22652. PubMed ID: 33251692
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel virulence factor in Clostridium difficile that modulates toxin sensitivity of cultured epithelial cells.
Miura M; Kato H; Matsushita O
Infect Immun; 2011 Sep; 79(9):3810-20. PubMed ID: 21746858
[TBL] [Abstract][Full Text] [Related]
9. Toxicity assessment of Clostridium difficile toxins in rodent models and protection of vaccination.
Wang S; Rustandi RR; Lancaster C; Hong LG; Thiriot DS; Xie J; Secore S; Kristopeit A; Wang SC; Heinrichs JH
Vaccine; 2016 Mar; 34(10):1319-23. PubMed ID: 26614590
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile Toxin Biology.
Aktories K; Schwan C; Jank T
Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
[TBL] [Abstract][Full Text] [Related]
11. Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers.
Stubbe H; Berdoz J; Kraehenbuhl JP; Corthésy B
J Immunol; 2000 Feb; 164(4):1952-60. PubMed ID: 10657645
[TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile toxins and enterococcal translocation in vivo and in vitro.
Feltis BA; Garni RM; Wells CL
J Surg Res; 2001 May; 97(1):97-102. PubMed ID: 11319888
[TBL] [Abstract][Full Text] [Related]
13. Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells.
Chaves-Olarte E; Weidmann M; Eichel-Streiber C; Thelestam M
J Clin Invest; 1997 Oct; 100(7):1734-41. PubMed ID: 9312171
[TBL] [Abstract][Full Text] [Related]
14. Repetitive domain of Clostridium difficile toxin B exhibits cytotoxic effects on human intestinal epithelial cells and decreases epithelial barrier function.
Zemljic M; Rupnik M; Scarpa M; Anderluh G; Palù G; Castagliuolo I
Anaerobe; 2010 Oct; 16(5):527-32. PubMed ID: 20620216
[TBL] [Abstract][Full Text] [Related]
15. Enterotoxins from Clostridium difficile; diarrhoeogenic potency and morphological effects in the rat intestine.
Torres J; Jennische E; Lange S; Lönnroth I
Gut; 1990 Jul; 31(7):781-5. PubMed ID: 2115017
[TBL] [Abstract][Full Text] [Related]
16. Rapid death of infant rhesus monkeys injected with Clostridium difficile toxins A and B: physiologic and pathologic basis.
Arnon SS; Mills DC; Day PA; Henrickson RV; Sullivan NM; Wilkins TD
J Pediatr; 1984 Jan; 104(1):34-40. PubMed ID: 6690674
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of C. difficile.
Martinez RD; Wilkins TD
J Med Microbiol; 1992 Jan; 36(1):30-6. PubMed ID: 1370542
[TBL] [Abstract][Full Text] [Related]
18. Clostridium difficile toxins may augment bacterial penetration of intestinal epithelium.
Feltis BA; Kim AS; Kinneberg KM; Lyerly DL; Wilkins TD; Erlandsen SL; Wells CL
Arch Surg; 1999 Nov; 134(11):1235-41; discussion 1241-2. PubMed ID: 10555639
[TBL] [Abstract][Full Text] [Related]
19. Effects of Clostridium difficile toxins A and B on cytoskeleton organization in HEp-2 cells: a comparative morphological study.
Fiorentini C; Arancia G; Paradisi S; Donelli G; Giuliano M; Piemonte F; Mastrantonio P
Toxicon; 1989; 27(11):1209-18. PubMed ID: 2515619
[TBL] [Abstract][Full Text] [Related]
20. EGA Protects Mammalian Cells from Clostridium difficile CDT, Clostridium perfringens Iota Toxin and Clostridium botulinum C2 Toxin.
Schnell L; Mittler AK; Sadi M; Popoff MR; Schwan C; Aktories K; Mattarei A; Azarnia Tehran D; Montecucco C; Barth H
Toxins (Basel); 2016 Apr; 8(4):101. PubMed ID: 27043629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
